Hirata Kazumasa
School of Pharmaceutical Sciences, Wakayama Medical University.
Yakugaku Zasshi. 2022;142(8):829-836. doi: 10.1248/yakushi.22-00004-4.
The first-phase third-party accreditation conducted by the Japan Accreditation Board for Pharmaceutical Education between FY 2013 and 2019 revealed various issues regarding current pharmacy education programs. In addition, the report of the Ministry of Health, Labour and Welfare's Study Group on the Training and Quality Improvement of Pharmacists, which was published in 2021, identified a broad range of issues in pharmaceutical education related to pharmacist training and quality improvement. Many of these issues are concerned with university curricula; thus, in order to ensure and enhance the quality of pharmaceutical education and develop pharmaceutical human resources that society demands, it is extremely important for each university to improve its curricula. Since revision of the model core curriculum for pharmaceutical education is currently underway, in this symposium, we held a discussion to identify points that need to be improved regarding the current model core curriculum to ensure and enhance the quality of pharmaceutical education in light of the above-mentioned issues, and incorporate the corresponding measures into the basic policy for revision of the model core curriculum.
日本药学教育认证委员会在2013财年至2019年期间进行的第一阶段第三方认证揭示了当前药学教育项目存在的各种问题。此外,厚生劳动省药剂师培训与质量提升研究小组于2021年发布的报告指出了药学教育中与药剂师培训和质量提升相关的一系列广泛问题。其中许多问题与大学课程有关;因此,为了确保和提高药学教育质量并培养社会所需的药学人才,各大学改进其课程极为重要。由于目前正在修订药学教育的示范核心课程,在本次研讨会上,我们进行了讨论,以根据上述问题确定当前示范核心课程需要改进的要点,以便确保和提高药学教育质量,并将相应措施纳入示范核心课程修订的基本政策中。